Addiction

<XMP><body> <script type="text/javascript"> //OwnerIQ var __oiq_pct = 50; if( __oiq_pct>=100 || Math.floor(Math.random()*100/(100-__oiq_pct)) > 0 ) { var _oiqq = _oiqq || []; _oiqq.push(['oiq_addPageBrand','Lycos']); _oiqq.push(['oiq_addPageCat','Internet > Websites']); _oiqq.push(['oiq_addPageLifecycle','Intend']); _oiqq.push(['oiq_doTag']); (function() { var oiq = document.createElement('script'); oiq.type = 'text/javascript'; oiq.async = true; oiq.src = document.location.protocol + '//px.owneriq.net/stas/s/lycosn.js'; var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(oiq, s); })(); } /////// Google Analytics var _gaq = _gaq || []; _gaq.push(['_setAccount', 'UA-21402695-21']); _gaq.push(['_setDomainName', 'angelfire.com']); _gaq.push(['_setCustomVar', 1, 'member_name', 'paramountrecovery', 3]); _gaq.push(['_trackPageview']); (function() { var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true; ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js'; var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s); })(); ////// Lycos Initialization ///////////////////// var lycos_ad = Array(); var lycos_search_query = ""; var lycos_onload_timer; var cm_role = "live"; var cm_host = "angelfire.lycos.com"; var cm_taxid = "/memberembedded"; var angelfire_member_name = "paramountrecovery"; var angelfire_member_page = "paramountrecovery/addiction.html"; var angelfire_ratings_hash = "1714659016:3aef40d7a5b05670f49a0c2533ad1c33"; var lycos_ad_category = null; var lycos_ad_remote_addr = "209.202.244.9"; var lycos_ad_www_server = "www.angelfire.lycos.com"; var edit_site_url = "www.angelfire.lycos.com/landing/landing.tmpl?utm_source=house&utm_medium=landingpage&utm_campaign=toolbarlink"; </script> <script type="text/javascript" src="https://scripts.lycos.com/catman/init.js"></script> <script type='text/javascript'> var googletag = googletag || {}; googletag.cmd = googletag.cmd || []; (function() { var gads = document.createElement('script'); gads.async = true; gads.type = 'text/javascript'; var useSSL = 'https:' == document.location.protocol; gads.src = (useSSL ? 'https:' : 'http:') + '//www.googletagservices.com/tag/js/gpt.js'; var node = document.getElementsByTagName('script')[0]; node.parentNode.insertBefore(gads, node); })(); </script> <script type='text/javascript'> googletag.cmd.push(function() { googletag.defineSlot('/95963596/ANG_300x250_dfp', [300, 250], 'div-gpt-ad-1450207484070-0').addService(googletag.pubads()); googletag.enableServices(); }); </script> <script type='text/javascript'> googletag.cmd.push(function() { googletag.defineSlot('/95963596/ANG_above_728x90_dfp', [728, 90], 'div-gpt-ad-1450207484070-1').addService(googletag.pubads()); googletag.enableServices(); }); </script> <script type='text/javascript'> googletag.cmd.push(function() { googletag.defineSlot('/95963596/ANG_below_728X90_dfp', [728, 90], 'div-gpt-ad-1450207484070-2').addService(googletag.pubads()); googletag.enableServices(); }); </script> <script type="text/javascript"> (function(isV) { if (!isV) { return; } //this.lycos_search_query = lycos_get_search_referrer(); var adMgr = new AdManager(); var lycos_prod_set = adMgr.chooseProductSet(); var slots = ["leaderboard", "leaderboard2", "toolbar_image", "toolbar_text", "smallbox", "top_promo", "footer2","slider"]; var adCat = this.lycos_ad_category; adMgr.setForcedParam('page', (adCat && adCat.dmoz) ? adCat.dmoz : 'member'); if (this.lycos_search_query) { adMgr.setForcedParam("keyword", this.lycos_search_query); } else if (adCat && adCat.find_what) { adMgr.setForcedParam('keyword', adCat.find_what); } for (var s in slots) { var slot = slots[s]; if (adMgr.isSlotAvailable(slot)) { this.lycos_ad[slot] = adMgr.getSlot(slot); } } adMgr.renderHeader(); adMgr.renderFooter(); }((function() { var w = 0, h = 0, minimumThreshold = 300; if (top == self) { return true; } if (typeof(window.innerWidth) == 'number' ) { w = window.innerWidth; h = window.innerHeight; } else if (document.documentElement && (document.documentElement.clientWidth || document.documentElement.clientHeight)) { w = document.documentElement.clientWidth; h = document.documentElement.clientHeight; } else if (document.body && (document.body.clientWidth || document.body.clientHeight)) { w = document.body.clientWidth; h = document.body.clientHeight; } return ((w > minimumThreshold) && (h > minimumThreshold)); }()))); window.onload = function() { var f = document.getElementById("lycosFooterAd"); var b = document.getElementsByTagName("body")[0]; b.appendChild(f); f.style.display = "block"; document.getElementById('lycosFooterAdiFrame').src = '/adm/ad/footerAd.iframe.html'; // Slider Injection (function() { var e = document.createElement('iframe'); e.style.border = '0'; e.style.margin = 0; e.style.display = 'block'; e.style.cssFloat = 'right'; e.style.height = '254px'; e.style.overflow = 'hidden'; e.style.padding = 0; e.style.width = '300px'; })(); // Bottom Ad Injection ( function() { var b = document.getElementsByTagName("body")[0]; var iif = document.createElement('iframe'); iif.style.border = '0'; iif.style.margin = 0; iif.style.display = 'block'; iif.style.cssFloat = 'right'; iif.style.height = '254px'; iif.style.overflow = 'hidden'; iif.style.padding = 0; iif.style.width = '300px'; iif.src = '/adm/ad/injectAd.iframe.html'; var cdiv = document.createElement('div'); cdiv.style = "width:300px;margin:10px auto;"; cdiv.appendChild( iif ); if( b ) { b.insertBefore(cdiv, b.lastChild); } })(); } </script> <style> #body .adCenterClass { margin:0 auto; display:block !important; overflow:hidden; width:100%; } #body .adCenterClass #ad_container { display:block !important; float:left; width:728px; } @media (min-width: 768px) {  #body .adCenterClass #ad_container { width: calc(100% - 372px); } } @media (min-width: 1110px) {  #body .adCenterClass #ad_container { width: calc(100% - 372px); } } </style> <div style="background:#abe6f6; border-bottom:1px solid #507a87; position:relative; z-index:9999999"> <div class="adCenterClass"> <a href="https://www.angelfire.lycos.com/" title="Angelfire.com: build your free website today!" style="display:block; float:left; width:186px; border:0"> <img src="/adm/ad/angelfire-freeAd.jpg" alt="Site hosted by Angelfire.com: Build your free website today!" style="display:block; border:0" /> </a> <div id="ad_container"> <script type="text/javascript">document.write(lycos_ad['leaderboard']);</script> </div> </div> </div>  <script type="text/javascript">document.write(lycos_ad['slider']);</script> <div id="lycosFooterAd" style="background:#abe6f6; border-top:1px solid #507a87; clear:both; display:none; position:relative; z-index:9999999"> <div class="adCenterClass" style="display:block!important; overflow:hidden; width:936px;"> <div id="aflinksholder" style="float:left; width:186px;"> <a href="https://www.angelfire.lycos.com/" title="Angelfire.com: build your free website today!" style="display:block; border:0"> <img src="/adm/ad/angelfire-freeAd2.jpg" alt="Site hosted by Angelfire.com: Build your free website today!" style="display:block; border:0" /> </a> </div> <iframe id="lycosFooterAdiFrame" style="border:0; display:block; float:left; height:96px; overflow:hidden; padding:0; width:750px"></iframe> </div> </div>  <script data-cfasync="false" language="javascript" async src="//udmserve.net/udm/img.fetch?sid=17754;tid=1;dt=6;"></script>  </xmp> Addiction

Enabling loved ones Ibogaine Judicial Advocacy photos of Active Addiction Video on Disease Concept Program Overview Experience, Strength, & Hope Recovery Overview House contact Confidential Application

ADDICTION COMMON DIAGNOSES According to the AMA and APA, Addiction to Alcohol and Other Drugs is a disease. This has been so since 1956 (AMA) and 1960 (APA). It quelifies as a disease because it meets the following criteria: 1. Primary: The illness exists in and of itself. (Addiction is secondary only to addiction but may manifest in addition to other illnesses.) 2. Chronic: Does not go away, fix itself, or spontaneously remit. 3. Progressive: worsens over time. 4. Symptomatic: Can be diagnosed through careful attention to the ways it manifests in a person's behavior and lifestyle. 5. Fatal: If left untreated. 6. Treatable: That is what this service is about. Additional questions.... 1. Are you afraid that if you ask for help you will lose your job or license? 2. So you work long hours at your office or clinic pharmacy or hospital setting? Is this your source of Pharmaceuticals? 3. Do you drink when you don't have your drug of choice? 4. Is your family expressing concern about your atttitude, isolation, driven behavior in other areas? 5. Have you had an experience of not remembering what you have said or done or even that you were present in a given situation? 6. Have you thought about killing yourself? 7. Are you an adult child of an alcoholic parent? 8. Do you find yourself looking for justification of your use? 9. Do you make decisions about where you live, who you live/associate with, what work you do, based on your continued ability to drink/use? If so there is a problem. THUMBNAIL SKETCH: ASKING THESE QUESTIONS OFTEN PROVIDES AN ANSWER. 1. When you drink or use a mood-altering chemical, can you predict what your feelings, mood, or behavior will be? 2. Do you experience negative results from your use and do it anyways? 3. Have you ever attempted to control your use? Were you successful?